Form 4: Director Diane Gulyas Receives Ingevity Stock Grant
Statement of Changes in Beneficial Ownership
Ingevity Corporation director Diane H. Gulyas was granted 1,904 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.
Summary
- Director Diane H. Gulyas acquired 1,904 shares of Ingevity Corporation common stock via a restricted stock unit grant.
- The grant was issued under the Ingevity Corporation 2025 Omnibus Incentive Plan.
- Following this transaction, the director's direct beneficial ownership increased to 14,788 shares.
- The director maintains an additional indirect holding of 3,747 shares held through a trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
Negatives
- None.
Risks
- Standard market risks associated with equity ownership in Ingevity Corporation.
Future Outlook
The restricted stock units are scheduled to vest in full on April 30, 2027.
Industry Context
StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to align director incentives with long-term shareholder value creation.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as a component of director compensation is consistent with standard practices among S&P 400 and similar mid-cap industrial companies.
Related Party Transactions
- The director holds 3,747 shares through the Diane H. Gulyas Trust, where the director serves as trustee and the spouse is the beneficiary.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation grant.
Next Steps
- Vesting of the 1,904 restricted stock units on April 30, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/30/2026 | Date of the restricted stock unit grant transaction. |
| 04/30/2027 | Vesting date for the granted restricted stock units. |
| 05/01/2026 | Date of filing for the Form 4. |
Keywords
Ingevity, NGVT, Form 4, Insider Trading, Director Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.